Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroarylaminoquinolines as TGF-beta receptor kinase inhibitors

Heteroarylaminoquinolines as TGF-beta receptor kinase inhibitors

US Patent 8987301 · Granted Mar 24, 2015

Estimated economic value: $65,013,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for t2025
Method of treating disorders using a pharmaceutical composition of oligopeptides2019
Compositions containing cyclic peptides and methods of use2019
3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one derivatives2019
Cyclic amides as MetAP-2 inhibitors2018
Pyrrolidinone derivatives as MetAP-2 inhibitors2018
Imidazo[4,5-C]quinolines as DNA-PK inhibitors2017
7-azaindole-2,7-naphthyridine derivative for the treatment of tumours2016
7-azaindole-2,7-naphthyridine derivative for the treatment of tumours2016
7-azaindole-2,7-naphthyridine derivative for the treatment of tumours2016
Use of EEF1A as biomarker and a method of screening MetAP2 inhibitors2015
Morpholinylquinazolines2015